Predictive Probability Early Termination Plans For Phase II Clinical Trials

DOI10.2307/2530109MaRDI QIDQ3857600zbMATH OpenOpenAlexWikidataFDO

Authors Jay Herson

Publication date 1979

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.2307/2530109

zbMATH Keywords

average sample sizeclinical trialspowerpredictive probability early termination planssize

Mathematics Subject Classification ID

Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical design (62L05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited in

(7)

• Data monitoring in complex clinical trials: Which treatment is better?
• Power calculations for replication studies
• Optimal and lead-in adaptive allocation for binary outcomes: a comparison of Bayesian methods
• CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH₀
• SEQUENTIAL METHODS IN CLINICAL TRIALS*
• A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials
• A predictive probability interim design for phase II clinical trials with continuous endpoints

This page was built for publication: Predictive Probability Early Termination Plans For Phase II Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3857600)